Michael Weisspapir, M.D., Ph.D.
Chief Medical Scientist, Pharcon Inc.
Professional Overview
Michael Weisspapir, M.D., Ph.D., is a medical scientist with extensive experience in experimental medicine. He has specialized in experimental pharmacology, immunopharmacology, toxicology, and neuroscience research.
His experience spans at least 19 years in interdisciplinary research and development in these scientific areas.
In corporate contexts, he has served as an executive, such as Chief Medical Officer (CMO) at pharmaceutical and biotech-related companies (e.g., as reported in historical public filings associated with AlphaRx, Inc.).
Before corporate affiliation, Weisspapir held a variety of research positions at major medical and research institutions, including:
- University of Tel Aviv and Rabin Medical Center in Israel;
- University Health Network and the University of Toronto in Canada.
Professional Experience
- Pharmaceutical consultant, RMW Pharma Consulting; PHARCON Inc.
- Chief medical officer, AlphaRx Canada
- Research Associate, Neuroscience Lab, Toronto Western Research Institute (University Health Network, Toronto, Canada)
- Senior Scientist, Cancer Immunology Lab, Felsenstein Medical Research Center, University of Tel Aviv and Rabin Medical Center, Israel
- Senior Scientist, Formulation Department, PHARMOS Ltd., Rehovot, Israel
- Assistant Professor, Department of Pharmacology, Chelyabinsk State Medical Institute, Russia
- Research Scientist, Toxicology Lab, Institute of Biophysics, Chelyabinsk, Russia
Scientific Contributions
Dr. Weisspapir is associated with 8 U.S. patents, more than 40 patent applications and has published more than 20 scientific articles. These include inventions in:
- drug delivery technologies (e.g., transmucosal delivery systems for peptides and biologically active compounds);
- cannabinoid pharmaceutical compositions;
- pharmaceutical formulations for inflammation and intraoral delivery systems.
Areas of Expertise
His scientific work bridges both basic experimental research and applied pharmaceutical innovation, especially in how drugs are formulated, delivered, and absorbed by the body
- Over 30 years of successful experience in pharmacology and drug development
- Extensive experience in interdisciplinary research and development: pharmacology, toxicology, pharmaceutical science, neuroscience
- Preclinical new drug development (immunomodulators, anti-inflammatory drugs, anticonvulsants, anticancer agents, antibiotics, antidiabetics)
- Pharmacological and toxicological evaluation of novel formulations for parenteral, oral, transdermal and topical applications
- Preformulation and formulation of new drug candidates
- Design and evaluation of different pharmaceutical dosage forms (solid, semisolid, liquid, parenteral, ophthalmic, topical)
- Evaluation of advanced pharmaceutical formulations (nanoemulsions, biodegradable nanoparticles)
- Experience in mammalian toxicology and safety pharmacology
